Abstract
Inflammatory processes occur as a result of the body's response to an aggressor agent and are associated with different diseases. These have caused the pharmaceutical industry to invest in researching new active substances and biomolecules with anti-inflammatory effects. In this field of research, interest is surging in discovering new pharmacological substances of natural origin. The use of probiotics, which involves employing beneficial microorganisms, dates back to the last century. Studies are now drawing the attention of the scientific community to their useful medicinal applications including anti-inflammatory activity. Several strains with confirmed probiotic action have been commercialized. However, studies are ongoing regarding the isolation of new strains and elucidation of the mechanisms of action, such as cell-to-cell interactions and antimicrobial and immunomodulatory activity. Among diseases that have an inflammatory component, those for which the use of probiotics has been studied include allergies, dermatitis, gastrointestinal and respiratory diseases, and cancer. It has been observed that administering probiotics to patients affected with these diseases exerts positive effects and improves the quality of their lives.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
